Skip to content

Cognitive Groove (Brought to You by GERAS DANCE)

Does Cognitive Groove (Brought to You by GERAS DANCE) Improve Physical Performance in Community-Dwelling Older Adults With Frailty: A Parallel Randomized Controlled Trial

Status
Recruiting
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT06870149
Acronym
GERAS DANCE
Enrollment
250
Registered
2025-03-11
Start date
2025-06-10
Completion date
2027-12-31
Last updated
2025-07-01

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Frail Older Adults, Frailty, Frailty in Aging, Frailty Syndrome

Keywords

Frailty, Rehabilitation, Dance

Brief summary

The goal of this clinical trial is to determine the effect of a community-based rehabilitation intervention (Cognitive Groove, Brought to you by GERAS DANCE), compared to usual care, on clinical outcomes in community-dwelling older adults living with frailty. The main questions it aims to answer are: 1. In community-dwelling older adults living with frailty, is Cognitive Groove more effective than usual care in improving functional movement, physical performance and strength? 2. In community-dwelling older adults living with frailty is Cognitive Groove more effective than usual care in improving frailty status, fear of falling, balance confidence, mood, cognition, grip strength, activities of daily living, life space mobility, loneliness, and quality of life? 3. As a community-based rehabilitation intervention, is Cognitive Groove a cost-effective intervention embedded within the community for older adults living with frailty after 12-months? Participants will participate in Cognitive Groove classes twice per week for 3 months or receive no intervention (usual care).

Interventions

OTHERDance Rehabilitation Intervention

Cognitive Groove (GERAS DANCE) presents a novel approach to increasing or maintaining independence and quality of life by improving physical performance and mobility using reminiscent music and rhythmic movement in a fun, safe environment. Cognitive Groove was designed to meet the complex needs of older adults with frailty. Our pilot quasi-experimental studies have demonstrated Cognitive Groove results in clinically significant improvements in walking speed by 0.1 m/s with enhanced temporal-spatial walking parameters and improved lower extremity function, including balance and chair stands.

Sponsors

McMaster University
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
DOUBLE (Investigator, Outcomes Assessor)

Eligibility

Sex/Gender
ALL
Age
65 Years to 100 Years
Healthy volunteers
No

Inclusion criteria

* Community-dwelling aged ≥65 years * At high risk for mobility disability/functional limitations as assessed by the FRAIL Scale ≥2 * Able to ambulate independently (25 m) with or without an assistive device * Able to follow two-step instructions * Medical clearance from referring clinician, or for self-referrals, medical clearance from family physician to safely participate in exercise * Can arrange transportation to the YMCA up to 2 times per week

Exclusion criteria

* Unable to speak or understand English * Current regular participation in a structured exercise program or receiving active physical therapy services * Severe cardiac or pulmonary disease * Unstable angina or heart failure * Severe osteoarthritis (e.g., awaiting joint replacement) * Parkinson's disease or other progressive neurological disorder * Receiving palliative care * Travel/commitments requiring missing more than two weeks

Design outcomes

Primary

MeasureTime frameDescription
Change in Physical PerformanceBaseline and 3-monthsPhysical function will be assessed with the Short Performance Physical Battery \[total score\]. Higher scores indicate better physical performance \[range 0-12\].

Secondary

MeasureTime frameDescription
Change in Walking SpeedBaseline and 3-monthsWalking speed will be assessed with the 400-m Walk Test \[walking speed, m/s\]. Faster walking speeds indicate better performance.
Change in Functional MobilityBaseline and 3-monthsFunctional mobility will be assessed with the Timed Up and Go (TUG) Test \[total time, s\]. A higher score indicates a greater falls risk (greater or equal to 12 sec) and lower functional mobility.
Change in Dual Task AbilityBaseline and 3-monthsDual-task ability will be assessed by the TUG-Cognitive (Dual Task Ability) \[total time, s\]. Higher time indicates worse performance.
Change in Static Postural ControlBaseline and 3-monthsStatic postural control will be assessed by the Single Leg Stance Test \[total time, s\]. Higher scores indicate better postural control.
Change in Hand Grip StrengthBaseline and 3-monthsHand grip strength will be assessed with a handgrip dynamometer \[kg\]. Higher measures indicate higher grip strength.
Change in CognitionBaseline and 3-monthsCognition will be assessed with the Montreal Cognitive Assessment \[total score\]. Higher scores indicate better cognition \[range 0-30\].
Change in FrailtyBaseline and 3-monthsFrailty will be assessed with the Fit-Frailty Index \[total score\]. Higher scores indicate greater frailty \[range 0-1\].
Change in Fear of FallingBaseline and 3-monthsFear of falling will be assessed by the Falls Efficacy Scale International (FES-I) \[total score\]. Higher scores indicate greater fear of falling \[range 16-64\].
Change in Balance ConfidenceBaseline and 3-monthsBalance confidence will be assessed by the Activities-specific Balance Confidence (ABC) Scale \[total score\]. Higher scores indicate higher confidence \[range 0-100\].
Change in Depression/MoodBaseline and 3-monthsDepression and mood will be assessed with the Patient Health Questionnaire-9 (PHQ-9) \[total score\]. Higher scores indicate more depressive symptoms \[range 0-27\].
Change in Basic Activities of Daily LivingBaseline and 3-monthsActivities of daily living will be assessed with the Katz activities of daily living questionnaire \[total score\]. Lower scores indicate greater impairment \[range 0-6\].
Change in Instrumental Activities of Daily LivingBaseline and 3-monthsActivities of daily living will be assessed with Lawton instrumental activities of daily living questionnaire \[total scores\]. Lower scores indicate greater impairment \[range 0-8\].
Change in Life Space MobilityBaseline and 3-monthsLife space mobility will be assessed with the Life Space Assessment \[total score\]. Higher scores indicate a larger life space \[range 0-120\].
Change in Health-related Quality of LifeBaseline, 3-months, and 12-monthsHealth-related quality of life will be assessed using the Health Utilities Index (HUI). Higher scores indicate better health-related quality of life \[range 0-1\].
Change in Healthcare UtilizationBaseline, 3-months, and 12-monthsNumber of emergency room visits and hospitalizations will be recorded. Higher number of visits indicates higher healthcare utilization.
Change in FallsBaseline to 3-monthsNumber of falls will be assessed by self-report and electronic health record.
Change in Falls-Related InjuriesBaseline to 3-monthsNumber of falls-related injuries will be assessed by self-report and electronic health record.
Change in MobilityBaseline to 3-monthsChange in mobility will be assessed by the total number of steps taken daily (e.g., Actigraph accelerometer). Higher number of steps indicates greater mobility.
AdherenceBaseline to 3-monthsClass attendance and homework completion will be recorded \[total number completed\]. Higher class attendance and homework completion indicates greater adherence.
Change in LonelinessBaseline and 3-monthsLoneliness will be assessed by the University of California Los Angeles (UCLA) Loneliness Scale \[total score\]. Higher scores in indicate higher loneliness \[range 20-80\].

Other

MeasureTime frameDescription
Individual-level Economic EvaluationBaseline, 3-months, and 12-monthsIndividual-level economic evaluations will be assessed by changes in direct medical costs and effectiveness outcomes (e.g., quality-adjusted life years - QALYs), calculate and compare the incremental cost-effectiveness ratio (ICER) (e.g., $/ QALY gained, $/ a visit averted) against a willingness-to-pay threshold ($50,000/QALY) to show if this program represents good value for money.

Countries

Canada

Contacts

Primary ContactPatricia Hewston, PhD
hewstonp@hhsc.ca905-521-2100

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: May 22, 2026